PATTIES FOODS - Frankfurt Stock Exchang (F:PH4) — Market Cap & Net Worth
Market Cap & Net Worth: PATTIES FOODS - Frankfurt Stock Exchang (PH4)
PATTIES FOODS - Frankfurt Stock Exchang (F:PH4) has a market capitalization of $891.27 Million (€762.35 Million) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #9631 globally and #1170 in its home market, demonstrating a -8.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PATTIES FOODS - Frankfurt Stock Exchang's stock price €0.99 by its total outstanding shares 1461101875 (1.46 Billion). Analyse PH4 cash flow metrics to see how efficiently the company converts income to cash.
PATTIES FOODS - Frankfurt Stock Exchang Market Cap History: 2025 to 2026
PATTIES FOODS - Frankfurt Stock Exchang's market capitalization history from 2025 to 2026. Data shows growth from $973.66 Million to $1.69 Billion (0.00% CAGR).
PATTIES FOODS - Frankfurt Stock Exchang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PATTIES FOODS - Frankfurt Stock Exchang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PH4 by Market Capitalization
Companies near PATTIES FOODS - Frankfurt Stock Exchang in the global market cap rankings as of May 4, 2026.
Key companies related to PATTIES FOODS - Frankfurt Stock Exchang by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
PATTIES FOODS - Frankfurt Stock Exchang Historical Marketcap From 2025 to 2026
Between 2025 and today, PATTIES FOODS - Frankfurt Stock Exchang's market cap moved from $973.66 Million to $ 1.69 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.69 Billion | +73.40% |
| 2025 | €973.66 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of PATTIES FOODS - Frankfurt Stock Exchang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $891.27 Million USD |
| MoneyControl | $891.27 Million USD |
| MarketWatch | $891.27 Million USD |
| marketcap.company | $891.27 Million USD |
| Reuters | $891.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PATTIES FOODS - Frankfurt Stock Exchang
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more